Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2007
12/06/2007US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide
12/06/2007US20070281363 Luminescent compounds
12/06/2007CA2653319A1 Hsp90 inhibitor
12/06/2007CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007CA2652158A1 Piperidinyl pyrimidine derivatives
12/06/2007CA2651368A1 Tumor suppressor
12/05/2007EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors
12/05/2007EP1861382A1 Fused aromatic compounds having anti-diabetic activity
12/05/2007EP1861380A1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
12/05/2007EP1861379A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
12/05/2007EP1861378A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
12/05/2007EP1861102A1 Use of 2-anilino-3,4-dihydro-quinazolines as 5ht5a receptor antagonists
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007CN101084214A 激酶抑制剂 Kinase inhibitors
12/05/2007CN101084199A Substituted amino-compounds and uses thereof
12/05/2007CN101084198A Substituted amino-pyrimidones and uses thereof
12/05/2007CN101084197A Process for preparing rosuvastatin
12/05/2007CN100352808C Heterocyclic diamide invertebrate pest control agents
12/04/2007US7304156 Preparation of aminopyrimidine compounds
12/04/2007US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels
11/29/2007WO2007113558A3 Quinazolinone derivatives having b-raf inhibitory activity
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007WO2007075895A3 Heterocyclic derivatives as modulators of ion channels
11/29/2007WO2007014927A3 Macrocyclic inhibitors of hepatitis c virus
11/29/2007US20070275985 Triazolopyrimidines
11/29/2007US20070275981 (Hetero)Cyclycarboxamides for Controlling Pathogenic Fungi
11/29/2007US20070275980 Amide Derivatives, Process For Preparation Thereof And Use Thereof As Insecticide
11/29/2007US20070275966 4'-(2-Oxo-5-(R)-phenyl-oxazolidin-3-ylmethyl) biphenyl-3-carboxylic acid (2-dimethylamino-ethyl)-amide, usedd for the treatment or prevention of neurological and psychiatric disorders
11/29/2007US20070275960 Phenyl and pyridyl compounds for inflammation and immune-related uses
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858882A1 Pyrimidine derivatives for treatment of hyperproliferative disorders
11/28/2007EP1858861A1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
11/28/2007EP1858520A2 Quinazolinone t-type calcium channel antagonists
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007CN101077867A Bis-aryl sulfonamides
11/28/2007CN100351243C Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351241C Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
11/28/2007CN100351240C Rosuvastatin calcium synthesis method
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/27/2007US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents
11/27/2007US7300940 Such as 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-(3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino- beta -alanine Hydrochloride; for therapy and prophylaxis of disease conditions that are associated with the biological activity of integrin receptors
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007US7300907 2-(Poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132146A1 Dhfr enzyme inhibitors
11/22/2007WO2007131621A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131620A1 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131619A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007US20070270589 Quinazoline Derivative and Process for Producing the Same
11/22/2007US20070270587 Pyrimidoindolones and methods for using same
11/22/2007US20070270446 Reversed Pyrimidinone Compounds as Calcilytics
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270425 Substituted pyrimidinyl oxime kinase inhibitors
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270416 Active Compound Combinations Having Insecticidal and Acaricidal Properties
11/22/2007DE102006021874A1 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, process for their preparation and their use as medicaments
11/22/2007CA2652341A1 Identification of cdki pathway inhibitors
11/22/2007CA2651658A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2651657A1 4,5-diphenyl-pyrimidinylamino substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2651466A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
11/21/2007EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1856109A1 Novell processes for the preparation of a benzofuran
11/21/2007EP1856091A1 Compounds for stabilizing factor vii polypeptide formulations
11/21/2007EP1856077A1 Piperazine derivatives as glyt1 inhibitors
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1856062A1 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine mediated diseases
11/21/2007EP1856061A1 Tetrahydro- and dihydroquinazolinones
11/21/2007EP1856060A1 Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds
11/21/2007EP1856059A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
11/21/2007EP1856053A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
11/21/2007EP1856046A1 Conjugates of metal complex hydroxypyridin derivatives and biomolecules and the use thereof for producing agents used in nmr diagnosis
11/21/2007EP1855685A2 Mitotic kinesin inhibitors
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN100349913C 2'-fluoronucleosides
11/21/2007CN100349890C Quinazoline(di) ones for invertebrate pest control
11/21/2007CN100349878C Process for preparation of 2-alkoxy-6-(trifluoromethyl)pyrimidin-4-ol
11/21/2007CN100349877C Preparation of aminopyrimidine compounds.
11/21/2007CN100349875C Reactive azo dye, method for the production and use thereof.
11/21/2007CN100349856C Propionic acid derivatives and their use as hPPARs activators
11/20/2007US7297808 Statin derivatives
11/20/2007US7297708 Central nervous system disorders; psychological disorders
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297700 rheumatoid arthritis, osteoarthritis, Parkinson's disease, uveitis, asthma, cardiovascular conditions including myocardial infarction, the treatment and prophylaxis of pain syndromes; e.g. 5,6,7,8-Tetrahydro-pyrido[3,4-d]pyrimidine-4-carboxylic acid cyclohexylmethyl-amide
11/20/2007US7297698 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/20/2007CA2171743C Nucleotide analogs
11/15/2007WO2007131034A1 Pyrimidone derivatives which are modulators of heat shock protein (hsp) 70
11/15/2007WO2007130783A2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
11/15/2007WO2007129020A1 Pyrimidine derivatives useful as dhfr inhibitors
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 427